0001193125-12-051847.txt : 20120210 0001193125-12-051847.hdr.sgml : 20120210 20120210133856 ACCESSION NUMBER: 0001193125-12-051847 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120210 DATE AS OF CHANGE: 20120210 GROUP MEMBERS: KATE MITCHELL GROUP MEMBERS: LOUIS C. BOCK GROUP MEMBERS: MARK BROOKS GROUP MEMBERS: RORY O'DRISCOLL GROUP MEMBERS: SCALE VENTURE MANAGEMENT II, LLC GROUP MEMBERS: SHARON WIENBAR SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Orexigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001382911 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 651178822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-83422 FILM NUMBER: 12591603 BUSINESS ADDRESS: STREET 1: 3344 N. TORREY PINES CT. STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 875-8600 MAIL ADDRESS: STREET 1: 3344 N. TORREY PINES CT. STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Scale Venture Partners II, LP CENTRAL INDEX KEY: 0001314703 IRS NUMBER: 201965001 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 950 TOWER LANE CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650.378.6050 MAIL ADDRESS: STREET 1: 950 TOWER LANE CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: BAVP VII LP DATE OF NAME CHANGE: 20050119 SC 13G/A 1 d299042dsc13ga.htm SCHEDULE 13G AMENDMENT NO. 4 Schedule 13G Amendment No. 4

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G/A

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)*

 

 

 

Orexigen Therapeutics, Inc.

(Name of Issuer)

 

 

 

Common Stock

(Title of Class of Securities)

 

68616404

(CUSIP Number)

 

12/31/11

(Date of Event Which Requires Filing of This Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

 

*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

Page 1 of 13 pages

 

CUSIP No. 68616404  

 

  1.   

Name of Reporting Persons

I.R.S. Identification No(s). of above person(s) (entities only)

 

Scale Venture Partners II, LP                    20-1965001

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)        (b)  

 

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      5.     

Sole Voting Power

 

3,088,278*

     6.     

Shared Voting Power

 

0

     7.     

Sole Dispositive Power

 

3,088,278*

     8.     

Shared Dispositive Power

 

0

  9.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

3,088,278*

10.

  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.

  

Percent of Class Represented by Amount in Row (9)

 

5.7%

12.

  

Type of Reporting Person (See Instructions)

 

PN

 

* Includes 70,833 shares one of the members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP, has the right to acquire within 60 days of 12/31/11 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

 

Page 2 of 13 pages

 

CUSIP No. 68616404  

 

  1.   

Name of Reporting Persons

I.R.S. Identification No(s). of above person(s) (entities only)

 

Scale Venture Management II, LLC                    27-0110811

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)        (b)  

 

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

California

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      5.     

Sole Voting Power

 

3,088,278*

     6.     

Shared Voting Power

 

0

     7.     

Sole Dispositive Power

 

3,088,278*

     8.     

Shared Dispositive Power

 

0

  9.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

3,088,278*

10.

  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.

  

Percent of Class Represented by Amount in Row (9)

 

5.7%

12.

  

Type of Reporting Person (See Instructions)

 

CO

 

* Shares are held by Scale Venture Partners II, LP. Scale Venture Management II, LLC is the general partner of Scale Venture Partners II, LP. Includes 70,833 shares one of the members of Scale Venture Management II, LLC has the right to acquire within 60 days of 12/31/11 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

 

Page 3 of 13 pages

 

CUSIP No. 68616404  

 

  1.   

Name of Reporting Persons

I.R.S. Identification No(s). of above person(s) (entities only)

 

Louis C. Bock

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)        (b)  

 

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

US

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      5.     

Sole Voting Power

 

0

     6.     

Shared Voting Power

 

70,833*

     7.     

Sole Dispositive Power

 

0

     8.     

Shared Dispositive Power

 

70,833*

  9.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

70,833*

10.

  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.

  

Percent of Class Represented by Amount in Row (9)

 

0.0%

12.

  

Type of Reporting Person (See Instructions)

 

IN

 

* Represents shares the reporting person has the right to acquire within 60 days of 12/31/11 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

 

Page 4 of 13 pages

 

CUSIP No. 68616404  

 

  1.   

Name of Reporting Persons

I.R.S. Identification No(s). of above person(s) (entities only)

 

Kate Mitchell

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)        (b)  

 

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

US

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      5.     

Sole Voting Power

 

0

     6.     

Shared Voting Power

 

3,088,278*

     7.     

Sole Dispositive Power

 

0

     8.     

Shared Dispositive Power

 

3,088,278*

  9.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

3,088,278*

10.

  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.

  

Percent of Class Represented by Amount in Row (9)

 

5.7%

12.

  

Type of Reporting Person (See Instructions)

 

IN

 

* Shares are held by Scale Venture Partners II, LP. Kate Mitchell, Rory O’Driscoll and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of her proportionate pecuniary interests therein. Includes 70,833 shares one of the members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP, has the right to acquire within 60 days of 12/31/11 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

 

Page 5 of 13 pages

 

CUSIP No. 68616404  

 

  1.   

Name of Reporting Persons

I.R.S. Identification No(s). of above person(s) (entities only)

 

Rory O’Driscoll

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)        (b)  

 

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

US

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      5.     

Sole Voting Power

 

0

     6.     

Shared Voting Power

 

3,088,278*

     7.     

Sole Dispositive Power

 

0

     8.     

Shared Dispositive Power

 

3,088,278*

  9.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

3,088,278*

10.

  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.

  

Percent of Class Represented by Amount in Row (9)

 

5.7%

12.

  

Type of Reporting Person (See Instructions)

 

IN

 

* Shares are held by Scale Venture Partners II, LP. Kate Mitchell, Rory O’Driscoll and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of his proportionate pecuniary interests therein. Includes 70,833 shares one of the members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP, has the right to acquire within 60 days of 12/31/11 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

 

Page 6 of 13 pages

 

CUSIP No. 68616404  

 

  1.   

Name of Reporting Persons

I.R.S. Identification No(s). of above person(s) (entities only)

 

Mark Brooks

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)        (b)  

 

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

US

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      5.     

Sole Voting Power

 

0

     6.     

Shared Voting Power

 

0

     7.     

Sole Dispositive Power

 

0

     8.     

Shared Dispositive Power

 

0

  9.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

0

10.

  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.

  

Percent of Class Represented by Amount in Row (9)

 

0.0%

12.

  

Type of Reporting Person (See Instructions)

 

IN

 

 

Page 7 of 13 pages

 

CUSIP No. 68616404  

 

  1.   

Name of Reporting Persons

I.R.S. Identification No(s). of above person(s) (entities only)

 

Sharon Wienbar

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)        (b)  

 

  3.  

SEC USE ONLY

 

  4.  

Citizenship or Place of Organization

 

US

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With:

      5.     

Sole Voting Power

 

0

     6.     

Shared Voting Power

 

3,088,278*

     7.     

Sole Dispositive Power

 

0

     8.     

Shared Dispositive Power

 

3,088,278*

  9.

  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

3,088,278*

10.

  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.

  

Percent of Class Represented by Amount in Row (9)

 

5.7%

12.

  

Type of Reporting Person (See Instructions)

 

IN

 

* Shares are held by Scale Venture Partners II, LP. Kate Mitchell, Rory O’Driscoll and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. The Reporting Person disclaims beneficial ownership with respect to all such shares except to the extent of her proportionate pecuniary interests therein. Includes 70,833 shares one of the members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP, has the right to acquire within 60 days of 12/31/11 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

 

Page 8 of 13 pages

Item 1.

 

  (a) Name of Issuer

Orexigen Therapeutics, Inc.

 

  (b) Address of Issuer’s Principal Executive Offices

3344 N. Torrey Pines Ct., Suite 200

La Jolla, CA 92037

Item 2.

 

  (a) Name of Person Filing

Scale Venture Parnters II, LP; Scale Venture Management II, LLC; Louis C. Bock; Kate Mitchell; Rory O’ Driscoll; Mark Brooks; and Sharon Wienbar

 

  (b) Address of Principal Business Office or, if none, Residence

Scale Venture Partners II, LP: 950 Tower Lane, Suite 700, Foster City, CA 94404

Scale Venture Management II, LLC: 950 Tower Lane, Suite 700, Foster City, CA 94404

Louis C. Bock:

   950 Tower Lane, Suite 700, Foster City, CA 94404

Kate Mitchell:

   950 Tower Lane, Suite 700, Foster City, CA 94404

Rory O’Driscoll:

   950 Tower Lane, Suite 700, Foster City, CA 94404

Mark Brooks:

   950 Tower Lane, Suite 700, Foster City, CA 94404

Sharon Wienbar:

   950 Tower Lane, Suite 700, Foster City, CA 94404

 

  (c) Citizenship

Scale Venture Partners II, LP is organized in Delaware and Scale Venture Management II, LLC is organized in California. Each of Louis C. Bock, Kate Mitchell, Rory O’Driscoll, Mark Brooks and Sharon Wienbar are US citizens.

 

  (d) Title of Class of Securities

Common Stock

 

  (e) CUSIP Number

68616404

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable

 

Item 4. Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a) Amount Beneficially Owned:

 

Scale Venture Partners II, LP

      3,088,278 (1) 

Scale Venture Management II, LLC

      3,088,278 (1) 

Louis C. Bock

      70,833 (2) 

Kate Mitchell

      3,088,278 (1) 

Rory O’Driscoll

      3,088,278 (1) 

Mark Brooks

      0   

Sharon Wienbar

      3,088,278 (1) 

 

Page 9 of 13 pages

  (b) Percent of Class:

 

Scale Venture Partners II, LP

      5.7 % 
Scale Venture Management II, LLC      5.7 % 
Louis C. Bock      0.0 % 
Kate Mitchell      5.7 % 
Rory O’Driscoll      5.7 % 
Mark Brooks      0.0 % 
Sharon Wienbar      5.7 % 

 

  (c) Number of shares as to which the person has:

 

  (i) Sole power to vote or to direct the vote:

 

Scale Venture Partners II, LP      3,088,278 (1) 
Scale Venture Management II, LLC      3,088,278 (1) 

 

  (ii) Shared power to vote or to direct the vote:

 

Louis C. Bock      70,833 (2) 
Kate Mitchell      3,088,278 (1) 
Rory O’Driscoll      3,088,278 (1) 
Mark Brooks      0   
Sharon Wienbar      3,088,278 (1) 

 

  (iii) Sole power to dispose or to direct the disposition of:

 

Scale Venture Partners II, LP      3,088,278 (1) 
Scale Venture Management II, LLC      3,088,278 (1) 

 

  (iv) Shared power to dispose or to direct the disposition of:

 

Louis C. Bock      70,833 (2) 
Kate Mitchell      3,088,278 (1) 
Rory O’Driscoll      3,088,278 (1) 
Mark Brooks      0   
Sharon Wienbar      3,088,278 (1) 

 

(1) Shares are held by Scale Venture Partners II, LP. Scale Venture Management II, LLC is the General Partner of Scale Venture Partners II, LP. Kate Mitchell, Rory O’Driscoll and Sharon Wienbar are the Managing Members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP. Includes 70,833 shares one of the members of Scale Venture Management II, LLC, the general partner of Scale Venture Partners II, LP, has the right to acquire within 60 days of 12/31/11 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.
(2) Represents shares the reporting person has the right to acquire within 60 days of 12/31/11 pursuant to options outstanding to purchase shares of the Issuer’s common stock. Such member is deemed to hold the reported shares for the benefit of Scale Ventures Partners II, LP. Scale Venture Partners II, LP is deemed the indirect beneficial owner of the options.

 

Page 10 of 13 pages

Item 5. Ownership of Five Percent or Less of a Class

Not Applicable

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person

Not Applicable

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

Not Applicable

 

Item 8. Identification and Classification of Members of the Group

Not Applicable

 

Item 9. Notice of Dissolution of a Group

Not Applicable

 

Item 10. Certification

Not applicable

 

Page 11 of 13 pages

[SIGNATURE]

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 9, 2012

 

SCALE VENTURE PARTNERS II, LP      SCALE VENTURE MANAGEMENT II, LLC
By:  

Scale Venture Management II, LLC,

its General Partner

       

By:

  

/s/ Kate Mitchell

Name: Kate Mitchell

Title: Managing Member

     

By:

  

/s/ Kate Mitchell

Name: Kate Mitchell

Title: Managing Member

By:

  

/s/ Louis C. Bock

Name: Louis C. Bock

      By:  

/s/ Kate Mitchell

Name: Kate Mitchell

By:

  

/s/ Rory O’Driscoll

Name: Rory O’Driscoll

     

By:

  

/s/ Mark Brooks

Name: Mark Brooks

By:

  

/s/ Sharon Wienbar

Name: Sharon Wienbar

       

EXHIBITS

 

A: Joint Filing Agreement

 

Page 12 of 13 pages

EXHIBIT A

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Orexigen Therapeutics, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.

In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 9th day of February 2012.

 

SCALE VENTURE PARTNERS II, LP      SCALE VENTURE MANAGEMENT II, LLC
By:  

Scale Venture Management II, LLC,

its General Partner

       

By:

  

/s/ Kate Mitchell

Name: Kate Mitchell

Title: Managing Member

     

By:

  

/s/ Kate Mitchell

Name: Kate Mitchell

Title: Managing Member

By:

  

/s/ Louis C. Bock

Name: Louis C. Bock

      By:  

/s/ Kate Mitchell

Name: Kate Mitchell

By:

  

/s/ Rory O’Driscoll

Name: Rory O’Driscoll

     

By:

  

/s/ Mark Brooks

Name: Mark Brooks

By:

  

/s/ Sharon Wienbar

Name: Sharon Wienbar

       

 

Page 13 of 13 pages